Stock NBY NOVABAY PHARMACEUTICALS
Add to a list
To use this feature you must be a member
Log inSign up

Calendar NovaBay Pharmaceuticals

Equities

NBY

US66987P4090

Market Closed - Nyse
Other stock markets
 01:30:00 01/06/2024 am IST 		5-day change 1st Jan Change
3.44 USD -5.68% Intraday chart for NovaBay Pharmaceuticals -25.43% -51.82%
09/05 NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
09/05 Earnings Flash (NBY) NOVABAY PHARMACEUTICALS Reports Q1 Revenue $2.63M, vs. Street Est of $3.28M MT

Chart calendar NovaBay Pharmaceuticals

8fe00e8c208cc2abfa0c.U5euqAigy_dwvOxiBvOD2-pQy1uEfHPqMSGf1JjyQRg.Ns3C3jrxiLAV2asUSsHHuZojpWvMOzjHX1HTvtfDKmwX3cTPJZiKmknx1A~44c9ad8445d376a51b6753329765102d

Upcoming events on NovaBay Pharmaceuticals

08/08/2024 Q2 2024 Earnings Release (Projected)
07/11/2024 Q3 2024 Earnings Release (Projected)
27/03/2025 Q4 2024 Earnings Release (Projected)
08/05/2025 Q1 2025 Earnings Release (Projected)

Past events on NovaBay Pharmaceuticals

28/05/2024 11:30 pm Annual General Meeting
10/05/2024 02:00 am Q1 2024 Earnings Call
10/05/2024 01:35 am Q1 2024 Earnings Release
27/03/2024 02:00 am Q4 2023 Earnings Call
27/03/2024 01:35 am Q4 2023 Earnings Release
16/11/2022 Reverse Split: 1 of 35
12/08/2022 02:00 am Interim 2022 Earnings Call
12/08/2022 01:35 am Interim 2022 Earnings Release
13/05/2022 02:00 am Q1 2022 Earnings Call
13/05/2022 01:35 am Q1 2022 Earnings Release
30/03/2022 02:00 am FY 2021 Earnings Call
30/03/2022 01:35 am FY 2021 Earnings Release
01/02/2022 12:30 am Extraordinary Shareholders Meeting - Third Call
14/01/2022 Extraordinary Shareholders Meeting - Second Call
10/01/2022 05:30 pm H.C. Wainwright BioConnect Conference
17/12/2021 Extraordinary Shareholders Meeting - First Call
12/11/2021 03:00 am Q3 2021 Earnings Call
12/11/2021 02:35 am Q3 2021 Earnings Release
30/09/2021 02:00 am Acquisition of DERMAdoctor, LLC by NovaBay® Pharmaceuticals, Inc Call
13/09/2021 H.C. Wainwright Global Investment Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		6,60
6,97
-5.32%		9,93
10,5
-5.39%		8,42
9,14
-7.82%		14,4
14,2
1.22%		14,7
14,4
2.26%
14,8

EBITDA
Million USD		Released
Forecast
Spread 		-9,34
-8,30
-12.47%		-6,38
-5,70
-11.84%		-8,74
-6,80
-28.57%		-7,20
-4,50
-59.93%		-7,39
-5,50
-34.42%
-2,60

EBIT
Million USD		Released
Forecast
Spread 		-9,40
-8,99
-4.56%		-6,43
-6,48
0.76%		-8,86
-8,59
-3.17%		-7,68
-5,76
-33.33%		-7,60
-6,20
-22.52%
-3,35

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-9,65
-8,79
-9.81%		-11,0
-11,1
0.86%		-5,82
-8,59
32.16%		-10,6
-5,97
-77.84%		-9,64
-9,50
-1.47%
-3,35

Net income
Million USD		Released
Forecast
Spread 		-10,5
-8,80
-19.24%		-11,0
-11,1
0.82%		-6,56
-8,59
23.6%		-16,3
-5,97
-172.67%		-16,7
-9,50
-75.76%
-3,35

EPS
USD		Released
Forecast
Spread 		-588
-521
-12.94%		-380
-392
3.12%		-184
-221
16.67%		-353
-142
-149.38%		-139
-80,9
-71.43%
-9,45

Announcement Date26/03/2025/03/2129/03/2230/03/2326/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		2,63
3,26
-19.36%		3,05
3,51
-13.25%		3,83
3,74
2.3%		3,64
4,73
-22.98%		3,12
3,20
-2.38%		4,61
3,68
25.44%		3,27
3,55
-7.9%		3,73
3,40
9.62%		2,63
3,28
-19.79%
3,58


3,71


4,24


4,39


4,78

EBITDA
Million USD		Released
Forecast
Spread 		-2,35
-3,10
24.13%		-2,03
-2,30
11.65%		-0,34
-1,30
74%		-2,57
0,00
- 		-1,68
-1,80
6.5%		-1,30
-1,60
18.5%		-1,07
-1,40
23.93%		-3,34
-1,60
-108.81%		-2,42
-1,10
-120.36%
-0,90


-0,50


-0,20


0,10


0,10

EBIT
Million USD		Released
Forecast
Spread 		-2,38
-2,90
17.72%		-2,15
-2,53
14.94%		-0,46
-1,95
76.56%		-2,69
-0,76
-253.82%		-1,73
-2,10
17.43%		-1,36
-2,09
35.17%		-1,12
-1,65
32.16%		-3,39
-2,00
-69.55%		-2,44
-1,32
-84.55%
-1,08


-0,71


-0,24


-0,36


-0,11

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-0,11
-2,15
94.83%		-2,16
-2,38
9.45%		-0,14
-1,80
92.44%		-8,21
-0,76
-979.74%		-1,74
-2,10
17.19%		-2,04
-2,09
2.58%		-1,76
-1,65
-6.81%		-4,11
-2,00
-105.4%		-3,09
-1,32
-134.09%
-1,08


-0,71


-0,24


-0,36


-0,11

Net income
Million USD		Released
Forecast
Spread 		-0,11
-2,15
94.83%		-2,16
-2,38
9.45%		-5,79
-1,80
-221.83%		-8,21
-0,76
-979.74%		-1,74
-2,10
17.19%		-4,03
-2,09
-92.92%		-1,76
-1,65
-6.81%		-9,17
-2,00
-358.45%		-3,59
-1,32
-172.27%
-1,08


-0,71


-0,24


-0,36


-0,11

EPS
USD		Released
Forecast
Spread 		0,00
-36,8
- 		-49,0
-42,9
-14.29%		-123
-36,8
-233.33%		-152
-12,8
-1086.3%		-29,8
-31,9
6.59%		-44,5
-19,4
-128.83%		-13,0
-14,2
8.64%		-46,6
-10,5
-343.33%		-5,25
-5,25
0%
-3,15


-2,10


-0,35


-0,88


0,00

Announcement Date12/05/2211/08/2214/11/2230/03/2311/05/2310/08/2309/11/2326/03/2409/05/24-----

Upcoming sector events for NovaBay Pharmaceuticals

15/07/2024 11:15 am ADDLIFE AB: Q2 2024 Earnings Release
22/07/2024 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
24/07/2024 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
24/07/2024 IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
25/07/2024 LONZA GROUP AG: Q2 2024 Earnings Release
25/07/2024 10:30 am BACHEM HOLDING AG: Q2 2024 Earnings Release
26/07/2024 PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
26/07/2024 10:30 am BB BIOTECH AG: Q2 2024 Earnings Release
More events

Past sector events for NovaBay Pharmaceuticals

30/05/2024 01:31 am IMMUNOVANT, INC.: Q4 2024 Earnings Release
23/05/2024 04:30 pm CUREVAC N.V.: Q1 2024 Earnings Release
22/05/2024 10:30 am EVOTEC SE: Q1 2024 Earnings Release
22/05/2024 02:44 am ALVOTECH: Q1 2024 Earnings Release
21/05/2024 04:30 pm EXSCIENTIA PLC: Q1 2024 Earnings Release
17/05/2024 11:30 am BIOARCTIC AB: Q1 2024 Earnings Release
16/05/2024 01:35 am CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 GNI GROUP LTD.: Q1 2024 Earnings Release
15/05/2024 01:35 am KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NBY Stock
  4. Calendar NovaBay Pharmaceuticals